HIV-1 and the developing central nervous system

Developmental Medicine and Child Neurology

Volumn 40, Issue 12, 1998, Pages 843-846

  Tardieu, Marc ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INJURY; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; SHORT SURVEY; VERTICAL TRANSMISSION;

EID: 0031797425     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.1998.tb12363.x     Document Type: Short Survey

References (28)

1. Lobato MN, Caldwell MB, Ng R Oxtoby MJ, Pediatrie Spectrum of Disease Clinical Consortium. (1995) Encephalopathy in children with perinatally acquired human immunodeficiency virus infection .Journal of Pediatrics 126: 710-5.
2. Belman AL, Muenz LR, Marcus JC, Gocdert JJ, Landesman S, Rubinstein A, Goodwin S, Durako S, Willoughby A. (1996) Neurologic status of human immunodeficiency virus 1-infected infants and their controls: a prospective study from birth to 2 years. Pediatrics 98: 1109-18.
3. Blanche S, Tardieu M, Duliége AM, Rouzioux C, Le Deist F, Fukunaga K, Caniglia M, Jacomet C, Messiah A, Griscelli C. (1990) Longitudinal study of 94 symptomatic infants with maternofoetal H1V infection: evidence for a bimodal expression of clinical and biological symptoms. American Journal of Disease of Children 144: 1210-5.
4. Cohen SE, Mundy T, Karassik B, Lieb L, Ludwig DD, Ward J. (1991) Neuropsychological functioning in Human Immunodeficiency Virus type l seropositive children infected through neonatal blood transfusion. Pediatrics 88: 58-68.
5. Levenson Jr RL, Mellins CA, Zawadxki R, Kairam R, Stein X. (1992) Cognitive assessment of human immunodeficiency virus exposed children. American Journal of Disease of Children 146: 1479-83
6. Tardieu M, Mayaux MJ, Seibel N, Funck-Brentano I. Straub E, Teglas JP Blanche S. (1995) Cognitive assessment of school age children infected with maternally transmitted human immunodeficiency virus type 1. Journal of Pediatrics 126: 375-9.
7. Connor KM, Sperling RS, Gelber R, Kiselev P. Scott G, O'Sullivan MJ, Van Dyke R, Bey M, Shearer W, Jacobson RL et al. (199-4) Reduction of maternal-fetal transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 331: 1173-80.
8. Aleixo LF, Goodenow MM, Sleasman JW (1997) Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neon at es reduces pediatrie infection independent of an effect on levels of maternal virus. Journal of Pediatrics 130: 906-14.
9. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C. Valleron AJ, HIV Infection in Newborns French Collaborative Study Group. (1993) Timing of mother-to-child HIV-1 transmission depends on maternal status. AIDS 7: S49-S52.
10. Khrnst A, Lindsgren S, Dictor M. (1991) HIV in pregnant women and their offspring: evidence for late transmission Lancet 338: 203-7.
11. Gendelman HE, Lipton SE, Tardieu M, Pulliam L, Genis H Jett M, XhaiJ. Swindellis S, Bukrinsky M, Nottet H. (1994) The neuropathogenesis of HIV-1 infection. Journal of Leukocyte Biology 56: 589-98.
12. Janahi N, DiStefano M, Wallon C, Héry C, Chiodi F, Tardieu M. (1998) Induction of human immunodeficiency virus type 1 replication in human gliuf cells after proinflammatory cytokine stimulation: effect of IFNγ, ILlβ and TNFα on differentiation and chemokine production in glial cells. Glia 23: 304-15.
13. 2 regulatory pathways. Journal of Immunology 157: 2129-35.
14. Unnuzel A. Barnier JV Héry C, Huynh VT, Guibert B, Gray F, Vincent JD, Tardieu M. (1997) HIV-1 and its coat protein gp 120 induce apoptosis and activate JNK and ERK mirogen-activated protein kinascs in human neurons. Annals of Neurology 42: 847-56.
15. 2+]i homeostasis and induce neurotoxiciry in human embryonic neurons. European Journal of Neurosciences 17: 2285-93
16. Novelli VM. (1996) Assessing prognosis in infants infected with human immunodeficiency virus. Journal of Pediatrics 129:623-5.
17. Belman AL. (1992) AIDS and the child's central nervous system: pediatrie neurology. Pediatrie Clinics of North America 39:691-714.
18. European Collaborative Study. (1990) Neurologic signs in young children with human immunodeficiency virus infection. Pediatrie Infectious Diseases 9: 402-6.
19. Lambert G, Thea DM, Pliner V Steketee RW, Abrams HJ, Matheson R Thomas PA, Greenberg B, Brown TM, Bamji M et al. (1997) Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. Journal of Pediatrics 130: 890-7.
20. Lobato MN, Cakiwell B, Ng R Oxtoby MJ, Pediatrie Spectrum of Disease Clinical Consortium. (1995) Encephalopathy in children with perinatally acquired human immunodeficiency virus infcction.Journal of Pediatrics 126: 710-5.
21. Vazeux K, Lacroix-Ciaudo C, Blanche S, Cumont MC, Henin O, Gray F, Boceon-Gibod L, Tardieu M. (1992) Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome enccphziopathy. American Journal of Pathology 140: 137-44.
22. Mintz M, Tardieu M, Hoyt L, McSherry G, Mendclson I, Oleske J. (1996) Levodopa therapy improves motor function in HIV. infected children with extrapyramidal syndromes. Neurology 47: 1583-5.
23. Mayaux MI, Burgard M, TeglasJP, CottalordaJ, Krivine A, Simon F. Puel J, Tarnalet C, Dormont D, Masquelier B et al. (1996) Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. JAMA S75: 606-10.
24. Sperling RS, Shapiro HE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB. Jimenez E, Rouzioux C et al. (1996) Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. New England Journal of Medicine 335: 1621-9.
25. Shearer WT, Quinn TC, LaRussa H Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diax C, Pagano M et al. (1997) Viral load and disease progression in infants infected with human immunodeficiency virus type 1. New England Journal of Medicine 336: 1337-42.
26. Blanche S, Mayaux MJ, Rouzioux C, Teglas JP Firtion G, Monpoux F, Ciraru-Vigneron N, Meier F, Tricoire J, Courpotin C et al. (1994) Relationship between maternal status at delivery and disease progression in vertically HIV-1-infected children. New England Journal of Medicine. 330: 308-12.
27. Misrahi M, Teglas JR N'Go N, liurgard M, Mayaux MJ, Rouzioux C, Delfraissy JF, Blanche S. for the French Pediatrie HIV Infection Study Group. (1998) CCR5 chemokinc receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA 279: 277-80.
28. Scarlatti G, Tresoldi H, Björndal A, Fredriksson R, Colognesi C, Deng HK, Malnati MS, Plebani A, Siccardi AG. Littman DR et al. (1997) In vivo evolution of HIV-1 eoreceptor. usage and sensitivity to chemokine-mediated suppression. Nature Medicine 3: 1259-65.